WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

VESICULAR NANOCARRIERS: A NOVEL APPROACH FOR TRANSDERMAL DRUG DELIVERY

Joshah Varghese* and Zeenath A.

ABSTRACT

Novel drug delivery system aims to deliver drug at predetermined rate as per the requirement of body. Vesicular nanocarriers overcome various limits of the use of topical drug delivery. Since it has many advantages over conventional delivery systems for transdermal delivery systems. Vesicular nanocarriers like liposomes, Ethosomes, Transfersomes, Transethosomes, Niosomes etc. are found to be well renowned for drug targeting and are used in the treatment of skin fungal infections. Thus, vesicular nanocarriers become the choice in transdermal drug delivery.

Keywords: Vesicular nanocarriers, Liposomes, Ethosomes, Transfersomes, Transethosomes, Niosomes.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More